| Features |
| bapineuzumab for alzheimer's: don't write off negative results just yet, experts say.
- Valeo, Tom
|
| debate on fda policy: how should training on prescribing long-acting opioids be handled?.
- Samson, Kurt
|
| where the stem cell research funding is - state or federal? public or private?.
- Fallik, Dawn
|
| interferon found not to slow ms disability progression.
- Fitzgerald, Susan
|
| serum levels of antibodies to a potassium channel found higher in people with ms.
- Moran, Mark
|
| rare mutation associated with inhibiting alzheimer's disease.
- Valeo, Tom
|
| zonisamide found non-inferior to carbamazepine for newly diagnosed epilepsy.
- Valeo, Tom
|
| using induced stem cells from patients, scientists restore muscle protein deficits in model for limb girdle muscular dystrophy.
- Talan, Jamie
|
| investigators induce stem cells from fibroblasts of huntington's and identify molecules to block disease deficits.
- Talan, Jamie
|
| new data on the physiological substrates of cognitive reserve.
- Valeo, Tom
|
| two new mutations identified as potential therapeutic targets for glioblastoma multiforme.
- Talan, Jamie
|
| cdc report documents poor level of basic preventive services: a consequence? the incidence of strokes in the us.
- Valeo, Tom
|
| unraveling the mechanisms of rem sleep paralysis - with insights into other neurodegenerative disorders.
- Robinson, Richard
|
| Departments |
| up & coming: m. brandon westover, md, phd: on automated predictors of delayed stroke after subarachnoid hemorrhage.
- Rukovets, Olga
|